WHO Expert Committee on Biological Standardization (Record no. 27756)

MARC details
000 -LEADER
fixed length control field 04059nam a2200385Ia 4500
001 - CONTROL NUMBER
control field EBC284745
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240120130211.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cn|||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 050120s2004 sz a sb i100 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9241209240
035 ## - SYSTEM CONTROL NUMBER
System control number (MiAaPQ)EBC284745
035 ## - SYSTEM CONTROL NUMBER
System control number (Au-PeEL)EBL284745
035 ## - SYSTEM CONTROL NUMBER
System control number (CaPaEBR)ebr10075419
035 ## - SYSTEM CONTROL NUMBER
System control number (CaONFJC)MIL9743
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)317384275
040 ## - CATALOGING SOURCE
Original cataloging agency MiAaPQ
Transcribing agency MiAaPQ
Modifying agency MiAaPQ
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RA8
Item number .A25 no. 924 2004
110 2# - MAIN ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element WHO Expert Committee on Biological Standardization.
Subordinate unit Meeting
Number of part/section/meeting (52nd :
Date of meeting or treaty signing 2001 :
Location of meeting Geneva, Switzerland)
245 10 - TITLE STATEMENT
Title WHO Expert Committee on Biological Standardization
Medium [electronic resource] :
Remainder of title fifty-second report.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Geneva :
Name of publisher, distributor, etc. World Health Organization,
Date of publication, distribution, etc. 2004.
300 ## - PHYSICAL DESCRIPTION
Extent vii, 232 p. :
Other physical details ill.
490 1# - SERIES STATEMENT
Series statement WHO technical report series,
International Standard Serial Number 0512-3054 ;
Volume/sequential designation 924
500 ## - GENERAL NOTE
General note "The WHO Expert Committee on Biological Standardization met in Geneva from 26 to 30 November 2001"--Introd.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note 505 0 Introduction -- General. Developments in biological standardization. Bioterrorism. International nonproprietary names for biotechnology-derived medicinal products -- International guidelines, recommendations, and other matters related to the manufacture and quality control of biologicals. Guidelines on clinical evaluation of vaccines: regulatory expectations. Group C meningococcal conjugate vaccines. Inactivated oral cholera vaccines. Guidelines on viral inactivation and removal procedures intended to assure the viral safety of human blood plasma products. Pneumococcal conjugate vaccines. Potency assays for diphtheria and tetanus vaccines. Pertussis vaccines. Preventive human immunodeficiency virus vaccines. Cell substrate safety. Cell banks. Yellow fever. Poliomyelitis vaccine, oral. Transmissible spongiform encephalitis and the safety of biologicals. Antivenoms. Gene therapy. Discontinuation requirements -- International reference materials. Biological substances: international standards and reference reagents. International biological standards for in vitro diagnostic procedures. International reference materials for the diagnosis and study of transmissible spongiform encephalitis -- Antibodies. Human antibody against human platelet antigen 5b -- Blood products and related substances. International reference panels for the validation of serological and nucleic acid based test for the detection of hepatitis B, hepatitis C and human immunodeficiency virus in blood screening. Factors II, VII, X, plasma. Von Willebrand factor. Streptokinase. Unfractioned heparin and low-molecular-weight heparin -- Cytokines, growth factors and endocrinological substances. Human chorionic gonadotrophin. Ciliary neurotrophic factor. Prolactin and its glycosylated and non-glycosylated components -- Miscellaneous. Pertussis toxin standard -- Annex 1. Guidelines on clinical evaluation of vaccines: regulatory expectations -- Annex 2. Recommendations for the production and control of meningococcal group C conjugate vaccines -- Annex 3. Guidelines for the production and control of inactivated oral cholera vaccines -- Annex 4. Guidelines on viral inactivation and removal procedures intended to assure the viral safety of human blood products -- Annex 5. Biological substances: international standards and reference reagents -- Annex 6. Recommendations and guidelines for biological substances used in medicine and other documents.
533 ## - REPRODUCTION NOTE
Type of reproduction Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biological products
General subdivision Standards
Form subdivision Congresses.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drugs
General subdivision Standards
Form subdivision Congresses.
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element ProQuest (Firm)
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Technical report series (World Health Organization) ;
Volume/sequential designation 924.
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=284745">https://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=284745</a>
Public note Click to View

No items available.